Download the PDF Follicular lymphoma AVI-PDX models to predict the response to RCHOP We are thrilled to communicate the preliminary data of our ongoing FLINOVO program performed in collaboration with Dr. Pierre Sujobert (HCL, Centre hospitalier Lyon Sud and CIRI/Lyon...
An in vivo avian model of human melanoma to perform rapid and robust preclinical studies We are delighted to share the publication of our preclinical Melanoma AVI-PDXTM model. Our study was conducted with the Hospices Civils de Lyon, the Cancer Research Center of Lyon...
Download the press release This strategic acquisition expands ERBC Group’s non-clinical research and development testing portfolio, adding in ovo models for anticancer drug development. Baugy, France, January 18th 2023 – ERBC Group, a non-clinical contract research...
We are delighted to present the publication reporting our AVI-PDM™ model of breast cancers, and preclinical studies using our in vivo model conducted in collaboration with Erytech Pharma. Download the...
We are delighted to announce that the US patent office granted a patent for the technology of implantation of human tumoral cells within tissues of the avian embryo to create tumoral models representative of patient diseases. This in vivo process is at the core of the...
Commentaires récents